4.7 Article

Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Association of Physical Activity With Risk of Liver Fibrosis , Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease

Ho Soo Chun et al.

Summary: This study investigated the association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease (CVD) in nonalcoholic fatty liver disease (NAFLD) subjects. The study found that increasing levels of physical activity were associated with a reduced risk of fibrosis, sarcopenia, and CVD. Furthermore, higher levels of physical activity were also associated with a lower risk of fibrosis, sarcopenia, and CVD in subjects with sarcopenic obesity or lean NAFLD.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Endocrinology & Metabolism

Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus

Christian Labenz et al.

Summary: This study found that the coded prevalence of NAFLD in T2D patients is low, but it is associated with an increased risk of renal failure. While no association was observed with myocardial infarction, stroke, PAD, NAFLD patients were more frequently treated with DDP-4 inhibitors within the first year of T2D diagnosis and had similar metabolic control during follow-up compared to those without NAFLD.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2022)

Article Gastroenterology & Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

Jeffrey Lazarus et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects a significant portion of the global adult population, but has received little attention from the global public health community. This has led to a lack of inclusion of NAFLD in national and international strategies and policies for non-communicable diseases, highlighting the need for a more comprehensive public health response to the disease.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

NLR contributed to the diagnosis and detection of nonalcoholic fatty liver disease: A meta- analysis

Jiake Tang et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Ferenc Emil Mozes et al.

Summary: Liver biopsy is still necessary for fibrosis staging in patients with non-alcoholic fatty liver disease. This study evaluated the diagnostic performance of liver stiffness measurement, FIB-4 Index, and NAFLD Fibrosis Score, and showed that sequential combinations of markers can reduce the need for liver biopsies.
Article Endocrinology & Metabolism

Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China

Yebei Liang et al.

Summary: The study investigated the prevalence and incidence of MAFLD and its association with diabetes, CKD, and CVD. MAFLD was found to be associated with higher risks of incident diabetes, CKD, and CVD. Patients with MAFLD combined with excessive alcohol consumption and HBV infection had increased risks of incident diabetes compared with those without fatty liver.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Gastroenterology & Hepatology

From NAFLD to MAFLD: Implications of a Premature Change in Terminology

Zobair M. Younossi et al.

Summary: The article discusses the proposal to rename NAFLD to MAFLD, highlighting the shortcomings of the new term and warning that changing the name without a comprehensive understanding may have negative implications for the field. The recommendation is to establish a true international consensus group to assess the impact and consequences of the terminology change and make recommendations based on available evidence to move the field forward.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population

Pai-Feng Hsu et al.

Summary: The severity of steatosis in nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery atherosclerosis burden and risk of presence of coronary plaques, especially high-risk plaques, independent of traditional risk factors. This association is particularly significant in individuals under 65 years old, males, without metabolic syndrome, and with lower low-density lipoprotein cholesterol values.

LIVER INTERNATIONAL (2021)

Article Cardiac & Cardiovascular Systems

Three-dimensional speckle tracking echocardiography for early detection of left ventricular dysfunction in children with non-alcoholic fatty liver diseases

Doaa El Amrousy et al.

Summary: The study found abnormal lipid profiles and higher levels of troponin I in obese children with non-alcoholic fatty liver disease. Three-dimensional speckle tracking echocardiography revealed impaired left ventricular function in these children despite normal left ventricular fraction shortening by conventional echocardiography.

CARDIOLOGY IN THE YOUNG (2021)

Article Gastroenterology & Hepatology

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

Hokyou Lee et al.

Summary: This study found a high prevalence of fatty liver disease (FLD) among middle-aged Korean adults, with MAFLD having a significantly higher prevalence than NAFLD. Both NAFLD and MAFLD were associated with an increased risk of cardiovascular disease (CVD).

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Endocrinology & Metabolism

Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes

Minyoung Lee et al.

Summary: The study showed that hepatic steatosis and fibrosis were significantly associated with diastolic heart dysfunction in patients with type 2 diabetes, coupled with impaired myocardial glucose uptake.

DIABETES OBESITY & METABOLISM (2021)

Letter Gastroenterology & Hepatology

Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?

Xu Chen et al.

JOURNAL OF HEPATOLOGY (2021)

Article Health Care Sciences & Services

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease

Jiaofeng Huang et al.

Summary: This study found that MAFLD patients diagnosed with different numbers of metabolic conditions tended to be older, more likely to be female, and had more severe renal impairment and liver fibrosis. Additionally, MAFLD patients diagnosed with fewer metabolic conditions were more likely to have excessive alcohol consumption. Among patients diagnosed with a single metabolic condition, those with diabetes alone had the highest risk.

RISK MANAGEMENT AND HEALTHCARE POLICY (2021)

Review Endocrinology & Metabolism

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Serena Scapaticci et al.

Summary: NAFLD is the most prevalent form of chronic liver disease in children and adolescents worldwide, with a significant increase in affected young people in recent decades, mainly due to childhood obesity. Insulin resistance and abnormal glucose tolerance are key features of NAFLD, which is also closely associated with Metabolic Syndrome.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease

Tudor Parvanescu et al.

Summary: The study found that increased liver and heart stiffness in MetS patients are associated with impaired left ventricular diastolic function. Additionally, left atrial stiffness also predicted subclinical LV diastolic dysfunction in MetS patients and was significantly correlated with liver steatosis and fibrosis.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)

Article Cardiac & Cardiovascular Systems

Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis

Grzegorz Styczynski et al.

Summary: The study evaluated cardiac morphology and function in morbidly obese patients referred for bariatric surgery with liver biopsy. Those with nonalcoholic steatohepatitis (NASH) showed signs of left ventricular concentric remodeling and hyperdynamic circulation, indicating a potential additional risk factor for cardiovascular events in this population.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Review Peripheral Vascular Disease

Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis

Luan Rodrigues Abdallah et al.

CURRENT ATHEROSCLEROSIS REPORTS (2020)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

From NAFLD to MAFLD: when pathophysiology succeeds

Herbert Tilg et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Comparison of MAFLD and NAFLD diagnostic criteria in real world

Su Lin et al.

LIVER INTERNATIONAL (2020)

Article Cardiac & Cardiovascular Systems

Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography

Wenxing Chang et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2019)

Article Cardiac & Cardiovascular Systems

Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance

Justin McNair Canada et al.

AMERICAN JOURNAL OF CARDIOLOGY (2019)

Article Gastroenterology & Hepatology

Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction

Olubunmi O. Olubamwo et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease

Quentin M. Anstee et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Left ventricular morphology and function in adolescents: Relations to fitness and fatness

Katrin A. Dias et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Gastroenterology & Hepatology

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Thomas Karlas et al.

JOURNAL OF HEPATOLOGY (2017)

Article Endocrinology & Metabolism

Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction

Tracey G. Simon et al.

OBESITY (2017)